This week on the “The Readout LOUD” podcast, we remember our beloved colleague Helen Branswell, who died last week. We speak with colleagues, family, and public health leaders about her work and her ...
As a Boston judge heard a challenge to Medicaid work requirements, state Medicaid directors gathered in Maryland to figure ...
Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more
A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a ...
AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug ...
What state officials scrambling to implement Medicaid work requirements shared behind closed doors at the National ...
A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality ...
Bobby Senaha was among the first patients to use daraxonrasib, a new life-extending drug for pancreatic cancer. His wife ...
It’s yet to be seen whether Alnylam’s drug will actually slow progression of Huntington’s, but the field is lively.
Gilead Sciences agreed to pay $45 million to settle allegations of paying kickbacks that improperly influenced prescriptions ...
A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% ...
MAHA allies and nutrition experts want the Trump administration to act on ultra-processed foods before the elections.
The surprising departure of Calley Means comes just before an election that may serve as a referendum on the MAHA movement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results